266 related articles for article (PubMed ID: 26328498)
1. Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
Kuwahara J; Yamada T; Egashira N; Ueda M; Zukeyama N; Ushio S; Masuda S
Biol Pharm Bull; 2015; 38(9):1410-4. PubMed ID: 26328498
[TBL] [Abstract][Full Text] [Related]
2. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Muneoka K; Shirayama Y; Takigawa M; Shioda S
Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
[TBL] [Abstract][Full Text] [Related]
3. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Ishima T; Fujita Y; Hashimoto K
Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
[TBL] [Abstract][Full Text] [Related]
5. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T
J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658
[TBL] [Abstract][Full Text] [Related]
6. Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
Maertens C; Droogmans G; Verbesselt R; Nilius B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):158-65. PubMed ID: 12122503
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
8. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
[TBL] [Abstract][Full Text] [Related]
9. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity.
Matsushima-Nishiwaki R; Kamoi S; Kozawa O
Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477
[TBL] [Abstract][Full Text] [Related]
10. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kakuta A; Izumi T; Koyama T
Eur J Pharmacol; 2010 Nov; 647(1-3):90-6. PubMed ID: 20816814
[TBL] [Abstract][Full Text] [Related]
11. alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Massé F; Hascoët M; Bourin M
Behav Brain Res; 2005 Oct; 164(1):17-28. PubMed ID: 16081166
[TBL] [Abstract][Full Text] [Related]
12. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.
Hansen CH; Larsen LW; Sørensen AM; Halling-Sørensen B; Styrishave B
Toxicol In Vitro; 2017 Jun; 41():1-11. PubMed ID: 28179152
[TBL] [Abstract][Full Text] [Related]
13. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
15. The pharmacogenetics of the selective serotonin reuptake inhibitors.
Brøsen K
Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Jacobsen NW; Hansen CH; Nellemann C; Styrishave B; Halling-Sørensen B
Toxicol In Vitro; 2015 Oct; 29(7):1729-35. PubMed ID: 26162595
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.
Shinkai K; Toyohira Y; Yoshimura R; Tsutsui M; Ueno S; Nakamura J; Yanagihara N
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):65-72. PubMed ID: 17211600
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Carrasco JL; Sandner C
Int J Clin Pract; 2005 Dec; 59(12):1428-34. PubMed ID: 16351675
[TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
20. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
